ask="39.49"
ask_size="200"
average_daily_volume="1847670"
bid="37.25"
bid_size="100"
book_value="11.83"
change="+1.20"
change_from_200_day_moving_average="-17.49"
change_from_50_day_moving_average="-4.35"
change_from_52_week_high="-54.44"
change_From_52_week_low="7.26"
change_in_percent="+3.21%"
close="38.64"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.80"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70883000"
high="39.13"
high_52_weeks="93.08"
last_trade_date="1/3/2017"
last_trade_price="38.64"
last_trade_size="55541"
last_trade_time="4:00pm"
low="37.20"
low_52_weeks="31.38"
market_capitalization="3.32B"
moving_average_200_day="56.13"
moving_average_50_day="42.99"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="61.36"
open="38.15"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="-31.17%"
percent_change_from_50_day_moving_average="-10.11%"
percent_change_from_52_week_high="-58.49%"
percent_change_from_52_week_low="+23.14%"
previous_close="37.44"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.16"
price_per_sales="86.24"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.52"
stock_exchange="NMS"
symbol="ALNY"
volume="819306"
weeks_range_52="31.38 - 93.08"
